|
Index of reports
> Cases with Pyrexia (179)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 179 Next >>
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-27
Patient: female, weighing 67.6 kg (148.7 pounds)
Reactions: Nodule, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 90 mg, unk, 1 hr infusion on d2,d4,d6,d8,d10
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-01
Cytarabine
Dosage: 1.80 g, unk,continuous infusion d1 to d10
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Idarubicin HCL
Dosage: 48 mg, unk, on d1,d3,d5
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Other drugs received by patient: Fluconazole; Valaciclovir; Ceftazidime; Oxazepam; Leucoplenin
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Dyspnoea, Tachycardia, Atrial Fibrillation, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1470 mg
Start date: 2012-08-10
Daunorubicin HCL
Dosage: 570 mg
End date: 2012-08-06
Possible Cytarabine side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: female, weighing 87.8 kg (193.2 pounds)
Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 1.87 g, cyclic
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, unk
Indication: Mantle Cell Lymphoma
Mesna
Dosage: 600 mg/m2, unk
Indication: Mantle Cell Lymphoma
Methotrexate
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: 1 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-03-19
Velcade
Dosage: 2.77 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-12-31
Velcade
Dosage: 0.7 mg/m2, cyclic
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-02-26
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-16
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Dyspnoea, Tachycardia, Atrial Fibrillation, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1470 mg
End date: 2012-08-10
Daunorubicin HCL
Dosage: 570 mg
End date: 2012-08-06
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female
Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 52 mg/m2, dose level 3
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-13
End date: 2012-07-17
Cytarabine
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-12
Possible Cytarabine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Cytarabine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Disseminated Intravascular Coagulation, Hypotension, Continuous Haemodiafiltration, Pyrexia, Tumour Lysis Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 157 mg
Daunorubicin HCL
Dosage: 80 mg
Etoposide
Dosage: 15.7 mg
Possible Cytarabine side effects in male
Reported by a physician from Italy on 2012-08-13
Patient: male
Reactions: Pyrexia, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 500 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2012-06-25
Rituximab
Dosage: 375 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2012-06-25
Treanda
Dosage: 70 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2012-06-26
Other drugs received by patient: Fluconazole; Allopurinol; Tetracosactide; Sulfamethoxazole and Trimethoprim; Darbepoetin Alfa; Pegfilgastrim; Amoxicillin and Clavulanate Potassium
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 64.6 kg (142.1 pounds)
Reactions: Pulmonary Haemorrhage, Blood Culture Positive, Tachycardia, Hypotension, Bacterial Infection, Pyrexia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 17000 mg
End date: 2012-07-25
Etoposide
Dosage: 1275 mg
End date: 2012-07-25
Possible Cytarabine side effects in male
Reported by a physician from Italy on 2012-08-09
Patient: male
Reactions: Respiratory Failure, Chills, Pancytopenia, Condition Aggravated, Pyrexia, Lung Infection Pseudomonal, Septic Shock, Oxygen Saturation Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Alkeran
Dosage: 234mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-15
End date: 2012-02-15
Carmustine
Dosage: 500mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-10
End date: 2012-02-10
Cytarabine
Dosage: 668mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-11
End date: 2012-02-14
Etoposide
Dosage: 167mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-11
End date: 2012-02-14
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-08-09
Patient: male, weighing 75.5 kg (166.1 pounds)
Reactions: Diarrhoea Haemorrhagic, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carmustine
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-18
End date: 2012-05-18
Cytarabine
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-19
End date: 2012-05-22
Etoposide
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-19
End date: 2012-05-22
Mabthera
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-01-01
End date: 2012-05-01
Mabthera
Start date: 2012-05-18
End date: 2012-05-18
Melphalan
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Nexium; Leucovorin Calcium; Valacyclovir Hydrochloride
Possible Cytarabine side effects in 46 year old female
Reported by a individual with unspecified qualification from United States on 2012-08-08
Patient: 46 year old female
Reactions: Dyspnoea, Pain in Extremity, Myelodysplastic Syndrome, General Physical Health Deterioration, Pyrexia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Skin Discolouration, Central Nervous System Infection, Small Intestinal Haemorrhage, Cough
Adverse event resulted in: death
Drug(s) suspected as cause:
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: 400 ug, intravenous, every two months
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Melphalan (Melphalan) (Melphalen)
Indication: Diffuse Large B-Cell Lymphoma
Melphalan Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Rituximab (Rituximab) (Rituximab)
Indication: Diffuse Large B-Cell Lymphoma
Rituximab (Rituximab) (Rituximab)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Cytarabine side effects in 66 year old male
Reported by a physician from France on 2012-08-07
Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Etoposide
Dosage: 400 mg/m2 daily; uid/qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Melphalan Hydrochloride
Dosage: 250 mg total dose
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-03
Treanda
Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-27
End date: 2012-02-28
Treanda
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-06
Patient: female, weighing 64.6 kg (142.1 pounds)
Reactions: Hypotension, Tachycardia, Bacterial Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 17000 mg
End date: 2012-07-25
Etoposide
Dosage: 1275 mg
End date: 2012-07-25
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-01
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Malaise, Diarrhoea, Pyrexia, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 210 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-26
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-26
Possible Cytarabine side effects in female
Reported by a physician from Germany on 2012-07-31
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Abdominal Pain, Malaise, Vomiting, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Cytarabine
Methotrexate
Tasigna
Dosage: 400 mg, bid
Administration route: Oral
Start date: 2012-04-16
Tasigna
Dosage: 400 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-14
End date: 2012-04-14
Other drugs received by patient: Acyclovir; Cotrim
Possible Cytarabine side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-31
Patient: female, weighing 29.9 kg (65.8 pounds)
Reactions: Sphingomonas Paucimobilis Infection, Contusion, Clostridium Test Positive, Tachycardia, Rectal Haemorrhage, Pyrexia, Resuscitation, Heart Rate Decreased, Balance Disorder, Abdominal Distension, Pain in JAW, Lethargy
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
End date: 2012-07-12
Daunorubicin HCL
Dosage: 52 mg
End date: 2012-07-20
Dexamethasone
Dosage: 132 mg
End date: 2012-07-23
Methotrexate
Dosage: 12 mg
End date: 2012-07-20
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 2680 mg
End date: 2012-07-16
Vincristine Sulfate
Dosage: 3.1 mg
End date: 2012-07-20
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: male
Reactions: Confusional State, Pulmonary Hypertension, Febrile Infection, Pyrexia, Mixed Liver Injury, Multi-Organ Failure, Enterovesical Fistula, Bone Marrow Failure, Pneumothorax, Acute Respiratory Distress Syndrome, Thrombocytopenia, Metabolic Acidosis, Haemoptysis, Intestinal Obstruction, Appendicitis, Lung Disorder, Renal Impairment, Zygomycosis, Respiratory Acidosis, Oliguria, Aspergillosis, Sinus Tachycardia, Septic Shock, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 10 mg
Administration route: Oral
Start date: 2008-03-19
Afinitor
Dosage: 10 mg
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2008-03-13
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2008-03-13
End date: 2008-03-19
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2008-03-13
End date: 2008-03-15
Other drugs received by patient: Vancomycin
Possible Cytarabine side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 46 year old female
Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carmustine
Cyclophosphamide
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Cytarabine
Dosage: 1.5 g/d/m2 (1 cycle)
Doxorubicin Hydrochloride
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Idarubicin HCL
Dosage: 12 mg/d/m2 (1 cycle)
Melphalan Hydrochloride
Oncovin
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Vorinostat
Dosage: 1 cycle
Administration route: Oral
Possible Cytarabine side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient: 46 year old female
Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Myelodysplastic Syndrome
Oncovin
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Suberoylanilide Hydroxamic Acid
Dosage: 500 mg, tid
Administration route: Oral
Indication: Myelodysplastic Syndrome
Other drugs received by patient: Radiotherapy
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-07-26
Patient: male, weighing 13.9 kg (30.6 pounds)
Reactions: Capillary Nail Refill Test Abnormal, Tachycardia, Anaphylactic Reaction, Hypotension, Drug Hypersensitivity, Pyrexia, Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 7200 mg
Elspar
Dosage: 3600 unit
End date: 2012-07-18
Possible Cytarabine side effects in 17 year old male
Reported by a physician from United States on 2012-07-26
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Possible Cytarabine side effects in female
Reported by a physician from France on 2012-07-25
Patient: female, weighing 77.0 kg (169.4 pounds)
Reactions: Abdominal Pain, Confusional State, Chills, Pyrexia, Convulsion, Loss of Consciousness, Cerebral Hypoperfusion, Diarrhoea, Gamma-Glutamyltransferase Increased, Sepsis
Drug(s) suspected as cause:
Clofarabine
Dosage: 54.5 mg, on d2-d3-d4-d5 and d6
Indication: Acute Leukaemia
Start date: 2012-06-26
End date: 2012-06-30
Cytarabine
Dosage: 1825 mg, on d1-d2-d3-d4-and d5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
End date: 2012-06-29
Filgrastim
Dosage: 385 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-05
Other drugs received by patient: Plitician; Ambiosome; Actrapid; Magnesium Sulfate; Aluminum Hydroxide and Magnesium Trisilicate; Decan; Plitician; Acetaminophen; Cernevit-12; Miconazole; Tiorfan; Zofran
Possible Cytarabine side effects in 11 year old female
Reported by a physician from United States on 2012-07-23
Patient: 11 year old female, weighing 54.7 kg (120.3 pounds)
Reactions: Pancytopenia, Pyrexia, Caecitis, Enterocolitis Infectious
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-10
End date: 2012-06-04
Cytarabine
Etoposide
Dosage: 150 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-10
End date: 2012-06-04
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-10
End date: 2012-06-08
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis, Laryngospasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1-7
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Dosage: 12 mg/m2, on days 1-3
Indication: Acute Myeloid Leukaemia
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Cytarabine side effects in female
Reported by a individual with unspecified qualification from Netherlands on 2012-07-13
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Febrile Neutropenia, Pyrexia, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: last dose prior to sae 05/jun/2012
Start date: 2012-06-05
Cisplatin
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Cytarabine
Dosage: last dose prior to sae 06/jun/2012
Start date: 2012-06-06
Cytarabine
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-05
Dexamethasone
Dosage: last dose prior to sae 07/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Dexamethasone
Dosage: last dose prior to sae 08/jun/2012
Start date: 2012-06-05
Mabthera
Dosage: last dose prior to sae 08/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-08
Mabthera
Dosage: last dose prior to sae 09/jun/2012
Start date: 2012-06-09
Other drugs received by patient: Augmentin '125'; Ciprofloxacin HCL; Nexium; Fungizone; Keppra; Keppra; Valganciclovir; Allopurinol
Possible Cytarabine side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11
Patient: 61 year old female
Reactions: Rash Pustular, Nausea, Pyrexia, Oral Herpes, Erythema, Sensorimotor Disorder, Haemodialysis, Stem Cell Transplant, Mucosal Inflammation, Epidermal Necrosis, Mental Disorder, Nervous System Disorder, Renal Tubular Necrosis, Blister, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Other drugs received by patient: Vancomycin Hydrochloride; Melphalan Hydrochloride; Carmustine; Etoposide; Cefepime Hydrochloride
Possible Cytarabine side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Page 1 Next >>
|
